Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma

European Journal of Dermatology

Volumn 18, Issue 3, 2008, Pages 308-312

  Funk, Angela ^a   Hensley, Frank ^a   Krempien, Robert ^a   Neuhof, Dirk ^a   Van Kampen, Michael ^b   Treiber, Martina ^a   Roeder, Falk ^a   Timke, Carmen ^a   Herfarth, Klaus ^a   Helmbold, Peter ^a   Debus, Juergen ^a   Bischof, Marc ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KRANKENHAUS NORDWEST   (Germany)

Author keywords

Cutaneous T cell lymphoma; Mycosis fungoides; Radiotherapy; Total skin radiotherapy; TSEBT

Indexed keywords

ADULT; AGED; ANHIDROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DISEASE FREE SURVIVAL; EPITHELIOLYSES; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MALE; MYCOSIS FUNGOIDES; OVERALL SURVIVAL; PALLIATIVE THERAPY; REMISSION; SKIN DEFECT; THERAPY EFFECT; TOTAL SKIN ELECTRON THERAPY; TREATMENT RESPONSE;

ADULT; AGED; ELECTRONS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEZARY SYNDROME; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 44949187490     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0394     Document Type: Article

References (26)

1. Duvic M, Edelson R. Cutaneous T-Cell Lymphoma. J Am Acad Dermatol 2004; 51: 43-5.
2. Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med 2004; 350: 1978-88.
3. Willemze R, Meijer CJ. Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC. J Cutan Pathol 2006; 33: 18-26.
4. Diamandidou E, Colome M, Fayad L, et al. Prognostic factor analysis in mycosis fungoides/Sezary syndrome. J Am Acad Dermatol 1999; 40: 914-24.
5. Whittaker SJ, Marsden JR, Spittle M, et al. Joint British Association of Dermatologists and U.K. cutaneous lymphoma group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003; 149: 1095-107.
6. Paulli M, Berti E. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts II. Haematologica 2004; 89: 1372-88.
7. Vonderheid EC. Treatment planning in cutaneous T-cell lymphoma. Dermatol Ther 2003; 16: 276-82.
8. Gehrisch A, Dörr W. Effects of systemic or topical administration of sodium selenite on ealy radiation effects in mouse oral mucosa. Strahlenther Onkol 2007; 183: 36-42.
9. Scholtz W. Ueber den Einfluss der Roentgenstrahlen auf die Haut in gesundem und kranken Zustand. Arch Dermatol 1902; 59: 421.
10. Trump JG, Wright KA, Evans WW, et al. High energy electrons for the treatment of extensive superficial malignant lesions. AJR Am J Roentgenol 1953; 69: 623.
11. Becker M, Hoppe RT, Knox SJ. Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides. Int J Rad Oncol Biol Phys 1995; 32: 1445-9.
12. Jones GW, Rosenthal D, Wilson LD. Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sezary syndrome). Cancer 1999; 85: 1985-95.
13. Rampino M, Ragona R, Monetti U, et al. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999. Radiol Med (Torino) 2002; 103: 108-14.
14. Seegenschmiedt MH, Sauer R. The systematics of acute and chronic radiation sequelae. Strahlenther Onkol 1993; 169: 83-95.
15. Hoppe RT, Cox RS, Fuks Z, et al. Electron beam therapy for mycosis fungoides: the Stanford University experience. Cancer Treat Rep 1979; 63: 691-700.
16. 3+ lymphocytes. Strahlenther Onkol 2005; 181: 326-35.
17. Burg G, Zwingers T, Staegemeir E, et al. Interrater and infraroter variabilities in the evaluation of cutaneous lymphoproliferative T-Cell infiltrates. EORTC-cutaneous lymphoma project group. Dermatol Clin 1994; 12: 31 1-4.
18. Sakata K, Satoh M, Someya M, et al. Analysis of local control in patients with non- Hodgkins' s lymphoma according to the WHO classification. Strahlenther Onkol 2005; 181: 385-91.
19. Ysebaert L, Truc G, Dalac S, et al. Ultimate results of radiation therapy for T1-T2 mycosis mungoides (including reirradiation). Int J Radiat Oncol Biol Phys 2004; 58: 1128-34.
20. Kaye FJ, Bunn PA, Steinberg SM, et al. A randomized trial comparing combination electron beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321: 1748-90.
21. Jones G, Kacinski BM, Wilson LD, et al. Total skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma project group. J Am Acad Dermat 2002; 47: 364-70.
22. Momm F, Bartelt S, Haigis K, et al. Spectrophotometric skin measurement correlate with EORTC/RTOG-common toxicity criteria. Strahlenther Onkol 2005; 181: 392-5.
23. Olscewski T, Seegenschmiedt H. Radiotherapy of Langerhans' cell histiocytosis. Strahlenther Onkol 2006; 182: 629-34.
24. Jones G, Wilson LD, Fox-Goguen L. Total skin electron beam radiotherapy for patients who have mycosis fungoides. Hematol Oncol Clin North Am 2003; 17: 1421-34.
25. Wilson LD, Quiros PA, Kolenik SA, et al. Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma. J Am Acad Dermatol 1996; 35: 69-73.
26. Chen Z, Agnostelli AG, Wilson L, et al. Matching the dosimetry characteristics of a dual-field Stanford Technique to a customized single-field Stanford technique for skin electron therapy. Int J Radiat Oncol Biol Phys 2004; 59: 872-85.